Gilead Sciences (GILD) Financials

$174.66

$7.19 (4.29%)

As on 04-Nov-2026 14:37EST

Market cap

$211,814 Mln

Revenue (TTM)

$30,987 Mln

P/E Ratio

17.7

P/B Ratio

16.2

Div. Yield

0 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	30,987.00	29,442.00	28,754.00	27,116.00	27,281.00	27,305.00
Cost of Revenue	6,219.00	6,234.00	6,251.00	5,804.00	5,657.00	6,601.00
Gross Profit	24,768.00	23,208.00	22,503.00	27,116.00	21,624.00	20,704.00
Operating Expenses	26,126.00	11,507.00	20,841.00	11,808.00	14,294.00	10,786.00
Operating Profit (EBIT)	-1,252.00	11,701.00	1,662.00	7,605.00	7,330.00	9,918.00
Other Income	--	--	--	--	-581.00	-639.00
Profit before Tax	-2,533.00	9,796.00	690.00	6,859.00	5,814.00	8,278.00
Provision for Tax	1,330.00	1,286.00	211.00	-1,247.00	1,248.00	2,077.00
Profit after Tax (Net Income)	-3,863.00	8,510.00	480.00	5,665.00	4,592.00	6,225.00
Minority Interest	--	--	--	47.00	26.00	24.00
Consolidated Profit	--	--	--	--	4,592.00	6,225.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	13,038.00	22,702.00	19,330.00	22,833.00	21,240.00	21,069.00
Minority Interest	--	-84.00	-84.00	-84.00	-31.00	-5.00
Non-Current Liabilities	26,450.00	24,592.00	27,745.00	28,096.00	30,724.00	35,278.00
Current Liabilities	12,002.00	11,813.00	12,004.00	11,280.00	11,238.00	11,610.00
Total Liabilities	63,408.00	59,023.00	58,995.00	62,125.00	63,171.00	67,952.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	34,855.00	40,681.00	39,823.00	46,040.00	48,727.00	53,180.00
Current Assets	16,554.00	18,342.00	19,173.00	16,085.00	14,443.00	14,772.00
Total Assets	67,963.00	59,023.00	58,995.00	62,125.00	63,171.00	67,952.00
Total Debt*	26,231.00	24,936.00	26,711.00	24,987.00	25,230.00	26,695.00
Net Current Assets	--	6,529.00	7,169.00	4,805.00	3,990.00	3,446.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	10,019.00	10,828.00	8,006.00	9,072.00	11,384.00
Cash Flow from Investing Activities	--	-4,793.00	-3,449.00	-2,265.00	-2,466.00	-3,131.00
Cash from Financing Activities	--	-7,745.00	-3,433.00	-5,125.00	-6,469.00	-8,877.00
Net Cash Inflow / Outflow	--	--	--	--	137.00	-624.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	-3.15	6.79	0.38	4.51	3.63	4.93
Cash EPS ($)	--	8.99	2.58	6.53	5.30	6.56
Adjusted Book Value ($)	--	18.12	15.35	18.18	16.80	16.69
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	8.00	8.60	6.37	7.18	9.02
Free Cash Flow per Share ($)	--	7.55	8.19	5.91	6.60	8.56

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	18.17	1.02	12.02	9.75	12.79
ROE (%)	-21.14	40.49	2.28	25.71	21.71	31.70
ROA (%)	-5.57	14.42	0.79	9.04	7.00	9.13
EBIT Margin (%)	-4.91	36.75	5.80	28.05	24.74	33.98
Net Margin (%)	-12.47	28.90	1.67	20.89	17.20	23.34
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	6.54	0.02	0.06	-0.01	0.00	0.11
EBIT Growth (%)	-113.96	549.07	-78.08	12.68	-27.27	249.75
Net Profit Growth (%)	-147.63	1,672.92	-91.53	23.37	-26.23	4,960.98
EPS Growth (%)	-148.77	16.81	-0.92	0.24	-0.26	49.49
Book Value Growth (%)	-39.33	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	17.74	18.07	242.28	17.96	23.63	14.72
Price / Book Value	16.24	6.77	6.02	4.46	5.11	4.35
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	179.04	12.45	29.64	15.71	14.39	9.87
Close Price ($)	149.05	122.74	92.37	81.01	85.85	72.61
High Price ($)	157.29	128.70	98.90	88.29	89.74	74.12
Low Price ($)	108.46	88.57	62.07	72.87	57.17	57.93
Market Cap ($ Cr)	211,813.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	--	1.10	1.38	1.09	1.19	1.27
Short term debt to equity ratio	0.19	0.12	0.09	0.08	0.11	0.07
Current Ratio	1.38	1.55	1.60	1.43	1.29	1.27
Quick Ratio	1.22	1.40	1.45	1.27	1.15	1.13
Interest Coverage	-1.51	10.57	1.71	8.06	7.22	9.27

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	16.16	16.69	15.37	17.19	17.51	16.45
Asset Turnover	0.45	0.50	0.47	0.43	0.42	0.40
Receivable days	--	57.89	57.67	63.56	62.06	62.77
Inventory Days	--	102.06	102.17	103.65	100.88	91.33
Payable days	--	45.35	40.40	45.78	51.98	42.86
Cash Conversion Cycle	--	114.61	119.43	121.42	110.96	111.24

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)